Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $8.20 in the prior trading day, Health Catalyst Inc (NASDAQ: HCAT) closed at $8.08, down -1.46%. In other words, the price has decreased by -$1.46 from its previous closing price. On the day, 0.89 million shares were traded. HCAT stock price reached its highest trading level at $8.29 during the session, while it also had its lowest trading level at $7.8.
Ratios:
Our goal is to gain a better understanding of HCAT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.18 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.05.
On January 03, 2024, Evercore ISI Upgraded its rating to Outperform which previously was In-line but kept the price unchanged to $11.
On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $14.Barclays initiated its Overweight rating on January 03, 2024, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 16 ’24 when Llewelyn Linda sold 1,324 shares for $8.43 per share. The transaction valued at 11,161 led to the insider holds 115,599 shares of the business.
LINDA LLEWELYN bought 1,324 shares of HCAT for $11,175 on Sep 16 ’24. On Sep 06 ’24, another insider, Landry Benjamin, who serves as the General Counsel of the company, sold 2,466 shares for $7.39 each. As a result, the insider received 18,222 and left with 100,937 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 488599200 and an Enterprise Value of 436268032. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.63 while its Price-to-Book (P/B) ratio in mrq is 1.36. Its current Enterprise Value per Revenue stands at 1.457 whereas that against EBITDA is -10.461.
Stock Price History:
Over the past 52 weeks, HCAT has reached a high of $11.41, while it has fallen to a 52-week low of $5.42. The 50-Day Moving Average of the stock is 10.47%, while the 200-Day Moving Average is calculated to be 5.62%.
Shares Statistics:
The stock has traded on average 541.86K shares per day over the past 3-months and 600340 shares per day over the last 10 days, according to various share statistics. A total of 58.30M shares are outstanding, with a floating share count of 57.75M. Insiders hold about 4.50% of the company’s shares, while institutions hold 85.95% stake in the company. Shares short for HCAT as of 1724976000 were 2184421 with a Short Ratio of 4.03, compared to 1722384000 on 2200503. Therefore, it implies a Short% of Shares Outstanding of 2184421 and a Short% of Float of 3.6799999999999997.
